Galena Biopharma Reaches $20M Settlement In Securities Lawsuits
PORTLAND, Ore. — Galena Biopharma Inc. will pay $20 million to settle claims in both a securities class action lawsuit and a shareholder derivative lawsuit alleging that the company and certain...To view the full article, register now.
Already a subscriber? Click here to view full article